Prospective Study In Noninvasive Evaluation of Hepatic Fibrosis in Chronic Hepatitis B
This study is currently recruiting participants.
Verified September 2012 by Peking University First Hospital
Sponsor:
Peking University First Hospital
Collaborator:
Beijing Municipal Science & Technology Commission
Information provided by (Responsible Party):
hong zhao, Peking University First Hospital
ClinicalTrials.gov Identifier:
NCT01679769
First received: September 1, 2012
Last updated: NA
Last verified: September 2012
History: No changes posted
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Received Date ICMJE | September 1, 2012 | ||||
| Last Updated Date | September 1, 2012 | ||||
| Start Date ICMJE | May 2012 | ||||
| Primary Completion Date | Not Provided | ||||
| Current Primary Outcome Measures ICMJE | Not Provided | ||||
| Original Primary Outcome Measures ICMJE | Not Provided | ||||
| Change History | No Changes Posted | ||||
| Current Secondary Outcome Measures ICMJE | Not Provided | ||||
| Original Secondary Outcome Measures ICMJE | Not Provided | ||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||
| Descriptive Information | |||||
| Brief Title ICMJE | Prospective Study In Noninvasive Evaluation of Hepatic Fibrosis in Chronic Hepatitis B | ||||
| Official Title ICMJE | Not Provided | ||||
| Brief Summary | The aim of our study is to evaluate liver fibrosis using biochemical markers, FibroScan, and radiology methods in patients with chronic hepatitis B in mainland China. |
||||
| Detailed Description | Not Provided | ||||
| Study Type ICMJE | Observational | ||||
| Study Design ICMJE | Time Perspective: Prospective | ||||
| Target Follow-Up Duration | Not Provided | ||||
| Biospecimen | Not Provided | ||||
| Sampling Method | Non-Probability Sample | ||||
| Study Population | patients with chronic hepatitis B or compensated cirrhosis due to chronic HBV infection |
||||
| Condition ICMJE | Chronic Hepatitis B | ||||
| Intervention ICMJE | Not Provided | ||||
| Study Group/Cohort (s) | Not Provided | ||||
| Publications * | Not Provided | ||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status ICMJE | Recruiting | ||||
| Estimated Enrollment ICMJE | 720 | ||||
| Completion Date | Not Provided | ||||
| Primary Completion Date | Not Provided | ||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||
| Gender | Both | ||||
| Ages | 18 Years to 75 Years | ||||
| Accepts Healthy Volunteers | No | ||||
| Contacts ICMJE |
|
||||
| Location Countries ICMJE | China | ||||
| Administrative Information | |||||
| NCT Number ICMJE | NCT01679769 | ||||
| Other Study ID Numbers ICMJE | 2012-455, 81170386 | ||||
| Has Data Monitoring Committee | Not Provided | ||||
| Responsible Party | hong zhao, Peking University First Hospital | ||||
| Study Sponsor ICMJE | Peking University First Hospital | ||||
| Collaborators ICMJE | Beijing Municipal Science & Technology Commission | ||||
| Investigators ICMJE | Not Provided | ||||
| Information Provided By | Peking University First Hospital | ||||
| Verification Date | September 2012 | ||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||